Weekly injection trial aims to ease sleep apnea and promote weight loss
NCT ID NCT07434050
Summary
This study is testing whether weekly injections of an investigational drug called XW003 can help reduce breathing pauses during sleep and lower body weight in obese adults who have obstructive sleep apnea. Participants will receive either XW003 or a placebo injection for up to 48 weeks while continuing their standard sleep therapy. The main goal is to see if the drug safely improves sleep apnea severity and leads to weight loss.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rui Jin Hospital
Shanghai, Shanghai Municipality, 200025, China
Conditions
Explore the condition pages connected to this study.